MIAMI—Nue Life Health, a provider of at-home health care solutions, announced a partnership with Enthea, the leading benefit plan administrator specializing in psychedelic health care services. This collaboration establishes Nue Life Health as the first at-home ketamine provider on Enthea's network, marking a significant milestone in accessible psychedelic therapy.
With an exceptional safety record and a steadfast commitment to patient care, Nue Life Health joins the Enthea Network of vetted and credentialed psychedelic therapists. Nue Life Health's focus on integration, health coaching, and a holistic experience aligns seamlessly with Enthea's mission to provide effective psychedelic health care solutions. By leveraging the collective expertise of both organizations, this partnership will aim to innovation and redefine the accessibility and efficacy of psychedelic healthcare services.
Nue Life Health said this collaboration addresses the growing demand for accessible and personalized ketamine services, empowering patients to embark on transformative healing journeys within the comfort and convenience of their own homes. As part of Enthea's Network Nue Life Health brings certified ketamine practitioners to the forefront, ensuring patients receive the highest quality of care.
"At Nue Life Health, we are honored to partner with Enthea and become an at-home ketamine provider on the Enthea Network," said Juan Pablo Cappello, CEO at Nue Life Health. "Our shared vision of empowering individuals through accessible psychedelic health care services has paved the way for this transformative partnership. By leveraging Enthea's expertise as a benefit plan administrator, we are poised to revolutionize the delivery of at-home ketamine-assisted therapy, ensuring patients receive personalized care and support throughout their healing journeys."
Enthea's role as a benefit plan administrator specializing in psychedelic health care enables them to provide health plan benefit riders and single case agreement services to facilitate access to transformative therapies. Nue Life is an attractive partner for Enthea's line of work due to its safety record, patient-centered approach and commitment to effective aftercare.
"This collaboration with Nue Life Health represents a significant step forward in expanding access to ketamine-assisted therapy services," said Sherry Rais, co-founder and CEO at Enthea. "We are thrilled to welcome Nue Life Health to our network of trusted providers. Together, we will work towards ensuring that individuals seeking psychedelic therapies receive the compassionate care they deserve in the comfort of their homes."
